For mild localised rash at the injection site, apply a cold compress and monitor for 2448 hours
Designed for both men and women, it provides a straightforward way to include glutathione in the diet
What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation
Our pricing is transparent
For patients over 40 who are already losing muscle through natural aging, this matters
Ozempic is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm